Table 1 Patient characteristics
From: Inhaled drug delivery: a randomized study in intubated patients with healthy lungs
SCAT group (n = 8) | HH Off group (n = 6) | HH On group (n = 8) | ETT group (n = 9) | |
|---|---|---|---|---|
Age (years) | 52 ± 13 | 52 ± 17 | 52 ± 11 | 46 ± 8 |
Male, n (%) | 4 (50) | 3 (50) | 2 (25) | 3 (33.3) |
Height (cm) | 168 ± 9 | 172 ± 7 | 171 ± 6 | 172 ± 10 |
Body weight (kg) | 74 ± 10 | 77 ± 12 | 75 ± 17 | 78 ± 13 |
Ideal body weight (kg) | 63 ± 10 | 65 ± 9 | 63 ± 7 | 65 ± 10 |
Smoker, n (%) | 3 (37.5) | 0 | 1 (12.5) | 3 (33.3) |
Surgery, n (%) | ||||
Brain tumor resection | 3 (37.5) | 2 (33.3) | 5 (62.5) | 6 (66.6) |
Embolization of intracranial unruptured aneurysm | 2 (25) | 1 (16.6) | 0 | 0 |
Neurosurgical clipping of an unruptured intracranial aneurysms | 2 (25) | 3 (50) | 2 (25) | 1 (11.1) |
Stereotactic brain biopsy | 0 | 0 | 1 (12.5) | 1 (11.1) |
Other (Arnold Chiary malformation, epileptic focus resection) | 1 (12.5) | 0 | 0 | 1 (11.1) |
Lung function | ||||
FEV1 (% predicted value) | 94 ± 8 | 101 ± 13 | 92 ± 10 | 95 17 |
FVC (% predicted value) | 93 ± 7 | 101 ± 8 | 93 ± 14 | 95 18 |
FEV1/FVC | 83 ± 7 | 82 ± 4 | 82 ± 5 | 86 ± 5 |